This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_UVEAMELANOMA_EXALLC for full statistics.
Melanoma of uvea
CD2_UVEAMELANOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
342 |
4. Check minimum number of eventsNone |
342 |
5. Include endpointsNone |
342 |
6. Filter based on genotype QC (FinnGen only) |
342 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF6
Similar endpoints
↥List of similar endpoints to
Melanoma of uvea
based on the number of shared cases.
Similar with more cases:
- Melanoma of uvea
- Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)
- Malignant melanoma
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 342 | 158 | 184 |
| Unadjusted period prevalence (%) | 0.07 | 0.05 | 0.08 |
| Median age at first event (years) | 64.02 | 61.76 | 65.96 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 300
- Matched controls
- 3001
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
323.0
251
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
273.1
236.1
219
29
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
+∞
214.1
179
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
+∞
212.6
178
*
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
+∞
181.2
155
*
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
520.8
152.9
140
5
WX140
NOMESCO Finland
Parabulbar anesthesy
51.5
137.0
167
71
XCK10
NOMESCO Finland
Photography of fundus of eye
23.3
112.9
184
191
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
17.6
86.7
152
165
C69.3
ICD-10 Finland
Malignant neoplasm: Choroid
+∞
79.8
73
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
14.5
70.9
133
156
8720/3-C69.3
ICD-O-3
Malignant melanoma, NOS, of choroid
+∞
67.2
62
*
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
57.9
67.0
78
18
8720/3-C69.9
ICD-O-3
Malignant melanoma, NOS, of eye, NOS
+∞
60.5
56
*
C69.39
ICD-10 Finland
Malignant tumor in chorioidea other or unspecified histology
+∞
56.0
52
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
14.9
53.8
95
90
WX002
NOMESCO Finland
Sedation and analgesia
6.8
47.7
155
407
XCW99
NOMESCO Finland
Other investigative procedure of eye
8.2
46.9
121
227
C69.40
ICD-10 Finland
Malignant tumor of ciliary body without histology
+∞
32.9
31
*
ZXA05
NOMESCO Finland
Left side
4.3
29.5
151
572
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
16.8
28.6
46
32
1906B
ICD-9 Finland
Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]
+∞
25.4
24
*
ZXA00
NOMESCO Finland
Right side
3.8
25.1
153
649
S01ED51
ATC
timolol, combinations; ophthalmic
5.6
21.9
69
151
CH2S4
NOMESCO Finland
Photography of iris
236.4
21.9
22
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.2
21.7
96
301
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
26.6
21.3
29
12
C69.02
ICD-10 Finland
Malignant tumor in conjunctival melanoma
+∞
21.1
20
*
WX142
NOMESCO Finland
Sub-tenon anesthesy
213.4
19.8
20
*
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
6.5
19.1
52
94
C69.42
ICD-10 Finland
Malignant tumor of ciliary melanoma
+∞
18.9
18
*
3770
FHL
Placing a radiating plate on the surface of the eye with additional measures
+∞
18.9
18
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
13.7
18.1
31
25
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
23.6
17.1
24
11
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
12.7
15.9
28
24
8000/3-C69.3
ICD-O-3
Neoplasm, malignant of choroid
+∞
15.8
15
*
3779
FHL
Other operations in this group include disc removal
+∞
15.8
15
*
CF2S4
NOMESCO Finland
Photography of conjunctiva
89.8
15.7
17
*
CD2S4
NOMESCO Finland
Photography of eye
84.3
14.7
16
*
C69.45
ICD-10 Finland
Melanoma of iris
+∞
14.7
14
*
N02AA05
ATC
oxycodone; systemic
3.2
13.4
83
323
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
13.1
174
1065
C69.99
ICD-10 Finland
Malignant tumor in unspecified localization in eye or other unspecified histology
+∞
12.6
12
*
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
+∞
12.6
12
*
XCD20
NOMESCO Finland
Photoangiography of eye
9.1
12.6
26
31
CDC00
NOMESCO Finland
Enucleation of eye
135.3
12.5
13
*
D31.4
ICD-10 Finland
Benign neoplasm: Ciliary body
135.3
12.5
13
*
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
48.7
12.0
14
*
130
Kela drug reimbursment
Malignant tumour
3.7
12.0
55
171
Z51.5
ICD-10 Finland
Palliative care
4.3
11.9
45
117
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
124.5
11.5
12
*
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
36.5
11.4
14
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.3
11.1
158
970
180
Kela drug reimbursment
Interferon alfa
62.2
10.7
12
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
5.7
10.6
30
57
XX7GT
NOMESCO Finland
Selective internal radio therapy (SIRT) with Yttrium
+∞
10.5
10
*
H33.2
ICD-10 Finland
Serous retinal detachment
27.0
9.9
13
5
L01AX03
ATC
temozolomide; systemic
27.0
9.9
13
5
S01ED01
ATC
timolol; ophthalmic
4.8
9.8
32
72
H26.2
ICD-10 Finland
Complicated cataract
10.6
9.7
18
18
CA1ME
NOMESCO Finland
Ultrasound oculometry
18.3
9.5
14
8
C69.03
ICD-10 Finland
Malignant tumor of conjunctival carcinoma
+∞
8.4
8
*
C69.20
ICD-10 Finland
Retina
+∞
8.4
8
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
7.9
99
555
H33.0
ICD-10 Finland
Retinal detachment with retinal break
5.9
7.8
21
38
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
46.2
7.7
9
*
S01EC01
ATC
acetazolamide; systemic
5.7
7.7
21
39
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
25.7
7.6
10
*
H43.1
ICD-10 Finland
Vitreous haemorrhage
6.8
7.5
18
28
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
7.5
81
422
ZXA10
NOMESCO Finland
Bilateral
2.3
7.5
79
407
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.4
7.5
26
63
A04AA02
ATC
granisetron; systemic, transdermal
3.5
7.5
34
105
JN4CD
NOMESCO Finland
Very extensive body CT
4.3
7.1
25
62
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.5
7.0
32
100
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.3
6.5
60
289
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
71.3
6.4
7
*
D31.2
ICD-10 Finland
Benign neoplasm: Retina
71.3
6.4
7
*
A06AH03
ATC
naloxegol; oral
11.4
6.3
11
10
S01EA03
ATC
apraclonidine; ophthalmic
11.4
6.3
11
10
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
11.4
6.3
11
10
C79.41
ICD-10 Finland
Secondary malignant tumor of optic nerve and eye
+∞
6.3
6
*
CH3S4
NOMESCO Finland
Photography of iridocorneal angle
+∞
6.3
6
*
S01FA01
ATC
atropine; ophthalmic
27.3
6.3
8
*
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
5.6
6.2
17
32
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
12.9
6.1
10
8
H35.7
ICD-10 Finland
Separation of retinal layers
10.3
6.1
11
11
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.9
6.1
129
864
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
234
882
6.23
59.68
5.8
3.4
u/l
29.4
33.5
1.28
229
840
(40768441) Liver Pathology biopsy report
23
24
10.20
19.88
1.3
1.3
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
18
0
+∞
18.93
1.1
0.0
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
14
0
+∞
14.69
1.1
0.0
%
35.6
—
—
14
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
14
0
+∞
14.69
1.0
0.0
%
8.9
—
—
14
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
281
2170
2.65
11.18
14.5
7.6
u/l
90.6
79.1
1.69
271
2014
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
212
1509
2.07
9.43
10.3
6.5
umol/l
13.6
11.4
0.90
207
1426
(42870588) Differential panel, method unspecified - Blood
140
907
1.92
7.69
6.6
5.4
—
—
—
0
0
(4035726)
56
256
2.42
7.62
1.5
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
48
4.13
6.99
4.5
2.9
%
53.1
57.2
0.43
19
48
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
45
4.17
6.71
3.6
2.3
e9/l
4.2
4.5
0.22
18
45
(3013650) Neutrophils [#/volume] in Blood by Automated count
206
1585
1.75
5.90
13.6
8.9
e9/l
4.1
4.2
0.04
184
1394
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
190
1441
1.72
5.62
8.5
6.9
mmol/l
1.2
1.2
0.41
153
1218
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
131
909
1.72
5.29
3.0
2.6
u/l
53.2
57.0
0.96
122
834
(3024561) Albumin [Mass/volume] in Serum or Plasma
169
1263
1.67
5.12
7.0
4.8
g/l
33.9
35.0
1.50
154
1174
(3033658) Prothrombin time (PT) actual/Normal
106
710
1.71
4.79
5.4
4.0
%
88.8
87.6
0.19
106
697
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
59
334
1.93
4.62
3.7
4.2
ug/l
9.1
39.6
0.70
47
283
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
30
4.11
4.47
1.2
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
31
139
2.35
4.40
2.6
2.9
u/ml
19.3
1120.5
0.58
26
119
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
172
1326
1.60
4.37
7.4
6.4
mmol/l
1.2
1.2
0.06
160
1199
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
67
2.94
4.30
1.1
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
125
902
1.61
4.13
2.6
2.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
28
4.03
4.01
1.5
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
159
1222
1.56
3.98
7.9
9.8
inr
1.1
1.3
1.42
50
352
(3015377) Calcium [Moles/volume] in Serum or Plasma
130
961
1.57
3.82
6.8
3.2
mmol/l
2.4
2.4
0.06
112
841
(3019225) pH of Specimen
46
260
1.89
3.61
6.9
3.9
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
8
13
6.27
3.52
4.6
4.1
u/l
208.8
223.2
—
8
13
(3037121) Protein [Mass/volume] in Urine
23
100
2.39
3.51
4.7
3.2
g/l
0.4
0.3
—
10
38
(3013826) Glucose [Moles/volume] in Serum or Plasma
205
1695
1.52
3.50
5.8
5.5
mmol/l
6.9
6.8
0.23
193
1588
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
20
83
2.50
3.37
2.6
2.5
mg/l
1.8
1.6
0.38
20
73
(3007853) Bacteria identified in Skin by Aerobe culture
53
322
1.76
3.31
1.9
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
116
860
1.53
3.27
4.6
4.3
—
—
—
0
0
(3002256) Pathology report gross observation
54
335
1.73
3.14
1.3
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
87
616
1.55
2.99
2.9
3.0
mosm/kgh2o
475.6
552.6
3.45
80
523
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
227
2555
0.67
2.99
6.2
6.4
mmol/mol
41.2
40.8
0.22
211
2367
(40758558) Short blood count panel - Blood
96
704
1.51
2.80
9.2
6.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
245
2707
0.67
2.79
4.9
5.4
mmol/l
2.6
2.6
0.09
229
2462
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
227
2541
0.68
2.72
3.9
4.3
mmol/l
1.4
1.3
1.43
213
2302
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
235
2612
0.68
2.69
4.3
4.7
mmol/l
1.4
1.5
0.78
221
2373
(1761868) Lipid panel - Serum or Plasma
62
883
0.64
2.66
3.1
3.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
157
1283
1.41
2.55
7.3
5.7
%
57.9
58.0
0.04
152
1198
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
239
2634
0.69
2.42
4.5
4.8
mmol/l
4.5
4.5
0.25
222
2417
(3017143) Hepatitis C virus Ab [Presence] in Serum
39
238
1.72
2.42
1.5
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
154
1273
1.38
2.26
4.3
4.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
48
316
1.60
2.24
3.5
3.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
168
1412
1.37
2.21
7.4
5.7
e9/l
0.2
0.2
0.32
150
1241
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
39
245
1.67
2.19
1.5
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
37
230
1.68
2.16
4.2
4.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
165
1387
1.37
2.15
7.4
5.6
e9/l
2.4
1.9
0.61
145
1226
(3003458) Phosphate [Moles/volume] in Serum or Plasma
54
371
1.54
2.11
6.9
5.5
mmol/l
1.1
1.0
0.97
47
344
(3006315) Basophils [#/volume] in Blood
162
1369
1.35
2.00
7.4
5.5
e9/l
0.0
0.0
0.61
144
1185
(3001604) Monocytes [#/volume] in Blood
161
1361
1.35
1.98
7.5
5.5
e9/l
0.6
0.6
1.30
144
1174
(3008295) Osmolality of Serum or Plasma
9
33
2.77
1.94
1.1
1.2
mosm/kgh2o
290.0
278.1
—
9
23
(4062490)
7
22
3.23
1.89
1.3
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
112
901
1.36
1.88
5.2
4.1
ph
7.4
7.4
0.51
28
162
(3002582) Erythrocytes [#/volume] in Urine
115
929
1.36
1.88
3.1
3.5
e6/l
37.5
126.5
0.68
95
728
(3045788) Cell count panel - Pleural fluid
7
23
3.08
1.81
1.9
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
176
0.44
1.75
1.4
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
132
1102
1.32
1.71
2.6
2.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
31
2.62
1.67
1.1
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
127
1058
1.32
1.66
3.7
4.0
e6/l
95.9
97.8
0.02
98
780
(3042936) Bacteria identified in Isolate by Culture
60
446
1.42
1.60
2.2
2.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
247
2655
0.75
1.56
5.0
4.9
mmol/l
6.2
6.1
0.43
226
2399
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
20
115
1.79
1.56
8.4
3.7
mmol/l
25.9
25.1
0.25
20
107
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
7
28
2.53
1.46
1.7
1.3
u/l
179.1
273.6
—
7
28
(3005570) Glucose [Moles/volume] in Urine
7
29
2.44
1.40
2.3
2.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
6
23
2.64
1.37
4.7
2.6
—
60.3
—
0
6
(4024509)
5
17
2.97
1.36
2.0
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
37
0.00
1.35
0.0
1.1
—
1.3
—
0
10
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
40
0.00
1.33
0.0
1.1
—
4.3
—
0
17
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
41
0.00
1.32
0.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
34
2.38
1.30
2.3
1.9
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
18
2.80
1.29
1.0
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
35
246
1.47
1.27
2.0
3.0
ng/l
269.2
208.5
0.26
29
220
(3000850) Epithelial cells [#/volume] in Urine
81
658
1.30
1.24
2.6
2.7
e6/l
4.2
4.1
0.05
74
580
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
29
414
0.67
1.24
1.2
1.3
u/ml
42.9
9.9
0.72
12
151
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
55
423
1.36
1.22
3.2
2.4
%
20.8
22.3
0.49
49
370
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
83
678
1.30
1.22
2.7
2.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
284
2688
1.33
1.20
23.0
16.2
mg/l
27.6
25.1
0.53
246
2152
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
38
2.13
1.19
1.1
1.9
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
27
183
1.52
1.17
6.9
3.3
mmol/l
2.4
2.0
0.10
21
134
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
80
1.78
1.14
1.8
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
31
428
0.70
1.12
1.2
1.3
iu/ml
57.2
36.2
0.44
13
146
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
298
2848
1.36
1.11
18.1
11.1
u/l
28.3
25.9
1.48
289
2740
(3012441) Differential panel - Pleural fluid
7
31
2.28
1.11
1.6
1.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
41
1.97
1.09
3.5
2.0
pg
34.3
33.0
—
8
41
(3020876) Protein [Mass/time] in 24 hour Urine
5
21
2.40
1.09
3.2
2.0
—
—
—
0
0
(3009343) pH of Capillary blood
28
195
1.47
1.08
6.8
3.2
ph
7.4
7.4
—
5
25
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
44
335
1.36
1.05
4.5
3.3
umol/l
13.9
8.2
0.50
37
297
(3021960) Folate [Moles/volume] in Serum or Plasma
59
730
0.77
1.05
1.9
1.6
nmol/l
20.8
20.8
0.01
54
610
(3035350) Ketones [Presence] in Urine by Test strip
152
1353
1.22
1.05
3.6
4.2
estimate
0.0
0.0
0.00
38
254
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
16
250
0.62
1.05
2.3
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
22
2.29
1.03
1.0
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
125
1093
1.23
1.02
4.0
3.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
48
1.90
1.01
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
13
76
1.74
1.00
1.5
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
21
140
1.53
1.00
7.5
3.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
49
1.86
0.99
4.1
2.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
95
810
1.24
0.98
3.3
3.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
30
0.00
0.97
0.0
1.3
—
—
—
0
0
(4306422)
0
32
0.00
0.95
0.0
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
46
360
1.32
0.93
3.1
2.8
%
1.8
1.8
0.09
41
325
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
52
1.75
0.93
1.2
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
16
102
1.60
0.92
2.2
2.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
33
246
1.38
0.91
1.6
2.0
%
2.0
1.6
0.74
27
214
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
182
1667
1.20
0.89
4.3
3.3
u/l
90.7
50.2
2.10
172
1539
(3037756) Immunofixation for Serum or Plasma
11
64
1.74
0.87
1.6
1.3
—
—
—
0
0
(4034850)
16
104
1.56
0.86
17.6
14.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
69
578
1.24
0.84
5.6
2.9
mmol/l
2.5
2.5
0.77
59
504
(3037467) Urinalysis macro (dipstick) panel - Urine
205
1905
1.19
0.83
5.4
4.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
230
2433
0.83
0.83
5.2
4.6
mu/l
1.9
2.0
0.62
213
2174
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
25
181
1.41
0.82
1.6
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
24
0.00
0.79
0.0
4.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
108
1215
0.84
0.79
2.4
2.0
pmol/l
98.3
94.6
0.28
59
632
(3030467) Casts [#/volume] in Urine by Automated count
98
857
1.20
0.79
3.4
3.2
e6/l
0.6
0.5
0.15
83
651
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
103
905
1.20
0.78
3.0
3.5
—
—
—
0
0
(4268621)
0
27
0.00
0.77
0.0
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
80
921
0.83
0.75
5.0
4.4
%
21.8
21.4
0.09
44
455
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
100
1.52
0.74
1.9
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
117
0.59
0.69
1.6
1.3
—
—
—
0
0
(3013512) EKG study
101
897
1.18
0.68
4.2
4.2
—
—
—
0
0
(1002224) Polysomnography panel
5
93
0.53
0.68
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
85
744
1.19
0.68
3.5
3.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
62
1.63
0.65
6.3
3.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
10
62
1.63
0.65
1.1
1.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
23
172
1.36
0.65
6.8
8.0
mmol/l
23.2
24.6
0.93
23
172
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
129
0.61
0.65
1.6
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
95
1.49
0.65
3.2
2.4
u/ml
0.3
0.4
—
8
48
(21494755) Public health laboratory ask at order entry panel
10
153
0.64
0.64
1.7
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
36
289
1.27
0.64
2.8
3.7
mmol/l
1.4
2.1
0.63
28
235
(4281824)
5
29
1.73
0.64
1.4
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
49
1.65
0.62
1.1
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
10
63
1.60
0.62
7.4
3.8
mmol/l
1.4
2.4
—
5
38
(3013290) Carbon dioxide [Partial pressure] in Blood
10
63
1.60
0.62
7.4
3.8
kpa
4.9
4.9
—
10
63
(3027315) Oxygen [Partial pressure] in Blood
10
63
1.60
0.62
7.4
3.7
kpa
9.2
8.2
—
10
63
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
58
494
1.21
0.62
1.8
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
27
210
1.31
0.61
3.7
2.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.1
—
49.8
—
0
15
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.3
—
90.6
—
0
5
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
106
1.43
0.58
2.5
1.9
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.0
—
293.1
—
0
13
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
23
0.00
0.58
0.0
1.0
—
41.4
—
0
12
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.0
—
526.5
—
0
13
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
129
1401
0.87
0.57
2.3
2.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
29
360
0.79
0.56
8.6
8.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
84
748
1.16
0.55
3.5
4.6
estimate
0.0
0.0
0.50
33
244
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
68
596
1.18
0.54
4.0
4.1
ng/l
539.6
246.9
0.26
56
495
(3013707) Erythrocyte sedimentation rate by Westergren method
195
2056
0.88
0.54
4.8
4.1
mm/h
16.1
13.4
1.19
182
1875
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
91
1.45
0.53
1.4
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
59
672
0.85
0.50
3.4
3.0
ug/l
0.7
0.8
0.50
43
445
(3043409) Potassium [Moles/volume] in Arterial blood
7
107
0.65
0.49
4.4
3.5
mmol/l
4.0
4.0
—
7
97
(3021447) Carbon dioxide [Partial pressure] in Venous blood
35
291
1.23
0.49
2.6
3.7
kpa
5.6
5.7
0.38
35
283
(40760888) Immunoglobulin light chains.free panel - Serum
10
68
1.48
0.47
6.4
4.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
27
219
1.25
0.47
2.4
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
117
0.68
0.46
1.5
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
21
165
1.29
0.46
2.5
2.4
e9/l
4.2
3.8
0.36
15
120
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
13
95
1.38
0.44
4.7
4.2
mg/l
19.4
32.0
—
6
76
(3034860) Kappa light chains.free [Mass/volume] in Serum
13
95
1.38
0.44
4.8
4.2
mg/l
27.5
135.2
—
6
76
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
51
1.38
0.44
1.3
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
51
1.38
0.44
1.3
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
31
1.62
0.43
2.8
2.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
139
0.71
0.42
1.4
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
75
676
1.14
0.42
1.3
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
50
437
1.17
0.42
17.9
26.1
inr
1.5
1.3
—
7
55
(3051611) Lipemic interference index of Serum or Plasma
5
33
1.52
0.41
8.0
2.8
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
33
1.52
0.41
1.0
3.0
nmol/l
3.4
4.3
—
5
33
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
33
1.52
0.41
5.0
3.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(4027681)
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
17
0.00
0.40
0.0
2.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
17
0.00
0.40
0.0
1.6
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
34
1.48
0.40
3.2
3.9
umol/l
262.0
342.7
—
5
29
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
1.0
—
0
12
(3045414) Leukocytes [Presence] in Urine
15
115
1.32
0.39
1.9
1.9
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
19
0.00
0.39
0.0
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
128
1199
1.11
0.38
4.2
4.1
ng/l
34.2
45.4
0.68
96
901
(3022621) pH of Urine by Test strip
16
202
0.78
0.38
2.8
3.0
—
—
—
0
0
(3044889) 12 lead EKG panel
192
1999
0.91
0.35
4.0
4.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
37
321
1.17
0.35
1.4
1.3
titre
1413.3
558.9
—
6
76
(3019309) Folate [Moles/volume] in Red Blood Cells
67
608
1.13
0.35
1.9
1.7
nmol/l
1219.5
1234.1
0.05
59
470
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
55
493
1.14
0.35
2.9
3.1
e6/l
0.8
2.3
2.55
32
284
(3026493) Urate [Moles/volume] in Serum or Plasma
83
764
1.11
0.34
3.3
2.9
umol/l
5522.2
8811.8
0.26
70
642
(3003338) MCHC [Mass/volume]
210
2175
0.91
0.34
25.5
21.6
g/l
331.1
332.0
0.71
205
2164
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
191
1986
0.91
0.34
4.5
3.8
pmol/l
15.0
14.9
0.24
176
1752
(3021601) Nitrite [Presence] in Urine by Test strip
144
1367
1.09
0.32
4.9
5.6
estimate
0.0
0.0
0.00
36
251
(3036489) Thrombin time
7
99
0.70
0.31
2.1
2.0
s
22.1
22.3
—
7
93
(3021589) Normoblasts [#/volume] in Blood
129
1222
1.09
0.30
14.1
10.2
e9/l
0.0
0.0
0.61
112
1008
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
58
636
0.89
0.30
1.7
1.8
pmol/l
505.5
441.9
0.73
51
523
(3009542) Hematocrit [Volume Fraction] of Blood
226
2326
0.92
0.30
21.9
17.5
%
38.8
39.3
0.26
151
1567
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
57
1.23
0.29
1.3
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
145
1383
1.08
0.29
3.7
4.2
estimate
0.0
0.0
0.00
38
240
(3000991) Gas panel - Venous blood
22
258
0.84
0.28
11.3
9.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
24
279
0.85
0.28
9.2
7.5
mmol/l
1.6
1.4
0.30
24
269
(40768443) Skin Pathology biopsy report
9
118
0.76
0.28
1.3
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
29
253
1.16
0.27
2.1
3.0
kpa
4.4
4.3
0.09
29
244
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
84
897
0.92
0.26
2.4
2.1
u/l
239.3
211.9
0.12
78
840
(3010421) pH of Blood
10
77
1.31
0.26
8.1
3.6
ph
7.4
7.4
—
10
63
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
39
1.29
0.23
1.0
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
79
1.27
0.22
1.3
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
41
1.22
0.22
1.0
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
41
1.22
0.22
1.0
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
41
1.22
0.22
1.0
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
41
1.22
0.22
1.0
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
111
1059
1.07
0.21
3.8
4.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
42
1.19
0.21
1.0
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
42
1.19
0.21
1.2
1.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
11
0.00
0.21
0.0
1.2
—
420.6
—
0
5
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
11.2
—
0
11
(3023511) Choriogonadotropin [Units/volume] in Urine
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.9
—
61.4
—
0
10
(40765096) Chromosome analysis panel by Banding
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
9.6
—
0
12
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
36
326
1.12
0.21
1.3
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
101
961
1.07
0.21
3.4
3.3
ng/l
1088.5
1467.5
1.00
93
826
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
39
355
1.11
0.21
1.4
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
43
1.17
0.21
1.2
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
14
166
0.84
0.21
1.2
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
13
0.00
0.21
0.0
3.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
13
0.00
0.21
0.0
3.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
25
281
0.88
0.20
1.3
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
84
885
0.93
0.19
3.8
3.2
mg/l
101.8
274.3
0.74
63
571
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
39
358
1.10
0.18
1.3
1.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
23
258
0.88
0.18
6.3
3.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
30
330
0.90
0.18
1.4
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
163
0.85
0.17
1.2
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
82
1.23
0.17
1.6
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
87
911
0.94
0.17
3.7
3.1
mmol/l
7.4
7.5
0.08
73
741
(40768797) Stomach Pathology biopsy report
36
391
0.91
0.17
1.3
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
69
1.16
0.16
1.8
2.2
—
—
—
0
0
(4094501)
6
76
0.79
0.16
1.2
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
44
411
1.08
0.15
6.6
7.1
mmol/l
104.5
103.9
0.52
44
401
(3023103) Potassium [Moles/volume] in Serum or Plasma
287
2838
1.07
0.15
24.7
19.3
mmol/l
4.0
4.0
0.96
278
2764
(3019550) Sodium [Moles/volume] in Serum or Plasma
286
2828
1.07
0.14
24.6
19.2
mmol/l
139.6
139.7
0.06
279
2752
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
252
2556
0.95
0.14
21.3
15.3
ml/min/173m2
75.1
76.0
0.26
219
2122
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
18
161
1.12
0.13
13.5
13.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
15
134
1.12
0.11
1.1
1.2
iu/ml
63.6
169.4
—
5
48
(46235355) HIV 1 and 2 tests - Meaningful Use set
30
280
1.08
0.10
1.5
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
295
2926
1.06
0.10
31.7
23.6
e9/l
241.6
241.9
0.02
287
2849
(3024731) MCV [Entitic volume]
295
2926
1.06
0.10
31.5
23.5
fl
91.6
91.6
0.07
289
2880
(3035941) MCH [Entitic mass]
295
2926
1.06
0.10
31.5
23.5
pg
30.3
30.5
0.42
289
2879
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
37
349
1.07
0.10
4.9
4.7
%
32.1
32.0
0.03
28
229
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
156
0.89
0.10
1.2
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
295
2927
1.06
0.10
31.7
23.6
e9/l
7.3
6.8
1.51
288
2838
(3026361) Erythrocytes [#/volume] in Blood
295
2927
1.06
0.10
31.6
23.6
e12/l
4.4
4.4
0.73
287
2838
(3022806) Fractional oxyhemoglobin in Capillary blood
5
44
1.14
0.10
3.0
2.1
%
92.1
90.2
—
5
44
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
45
1.11
0.10
1.0
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
45
1.11
0.10
1.0
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
45
1.11
0.10
1.0
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
62
644
0.95
0.09
3.3
4.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
295
2928
1.05
0.09
31.8
23.8
g/l
132.2
134.6
1.82
290
2876
(3007164) IgA [Mass/volume] in Serum or Plasma
47
492
0.95
0.09
2.5
1.4
g/l
2.2
2.7
1.16
25
287
(3042631) Mycobacterium sp identified in Specimen
5
47
1.06
0.09
2.0
3.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
30
319
0.93
0.09
1.2
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
111
1137
0.96
0.09
5.5
5.1
ug/l
4.0
2.7
0.30
99
1005
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
76
736
1.04
0.09
2.3
2.1
mg/l
3.3
3.2
0.11
70
636
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
61
0.82
0.08
1.0
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
62
0.80
0.08
1.0
3.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
63
0.79
0.08
1.0
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
63
0.79
0.08
1.0
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
117
1.12
0.08
1.3
2.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
10
88
1.14
0.08
7.4
3.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
65
1.08
0.08
2.3
2.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
66
1.06
0.08
1.0
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
279
2769
1.04
0.08
19.7
15.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
72
0.83
0.07
1.5
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
74
1.08
0.07
2.0
1.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
37
353
1.05
0.07
8.0
9.3
kpa
5.2
5.1
0.24
32
340
(3019832) Treponema pallidum Ab [Presence] in Serum
9
84
1.07
0.07
1.4
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
37
354
1.05
0.07
7.9
9.4
mmol/l
1.5
1.4
0.06
28
285
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
10
111
0.90
0.06
2.6
2.3
ug/l
2068.6
382.0
—
10
103
(3019060) Gas panel - Arterial blood
20
213
0.94
0.06
4.7
6.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
51
526
0.96
0.06
1.3
1.2
u/ml
0.4
1.4
—
10
138
(3002179) Metamyelocytes/100 leukocytes in Blood
23
219
1.05
0.04
8.4
4.3
%
0.7
0.4
—
9
60
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
160
0.93
0.04
2.0
2.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
52
533
0.97
0.04
3.0
2.7
e6/l
1.0
1.1
0.04
30
317
(3049717) Cytology report of Urine Cyto stain
12
129
0.93
0.03
2.8
2.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
24
230
1.05
0.03
7.9
4.5
%
0.0
0.1
2.49
11
77
(3000492) Spirometry study
24
230
1.05
0.03
1.9
1.4
—
—
—
0
0
(4010399)
19
199
0.95
0.03
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
108
0.92
0.03
6.0
4.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
25
241
1.04
0.03
2.3
3.1
ml/min/173m2
49.7
61.1
—
9
112
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
188
0.96
0.02
1.4
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
21
218
0.96
0.02
8.0
4.6
%
0.0
0.2
0.66
11
66
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
63
621
1.02
0.02
1.9
1.7
mg/l
1.2
1.4
0.36
51
487
(3020682) Albumin/Creatinine [Ratio] in Urine
93
939
0.99
0.01
4.4
4.0
mg/mmol
19.0
9.5
0.81
70
591
(3019150) Specific gravity of Urine by Refractometry
62
612
1.02
0.01
3.4
4.8
kg/l
1.0
1.0
0.10
11
92
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
115
1142
1.01
0.01
2.4
2.2
nmol/l
77.7
77.4
0.04
104
1006
(40760892) CBC W Ordered Manual Differential panel - Blood
60
607
0.99
0.01
8.9
5.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
138
1.02
0.00
1.6
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
14
142
0.99
0.00
1.2
1.3
—
35.2
—
0
10
(3017181) Myelocytes/100 leukocytes in Blood
25
249
1.00
0.00
8.0
4.3
%
0.5
0.8
0.32
11
86
(3005322) IgE [Units/volume] in Serum or Plasma
13
133
0.98
0.00
1.1
1.2
u/ml
48.1
152.7
2.29
13
125
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
115
1.05
0.00
1.0
1.0
—
—
—
0
0
(3020891) Body temperature
13
125
1.04
0.00
4.2
4.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
176
1.02
0.00
4.1
4.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
24.2
—
0
5
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
135.2
—
0
6
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
8
82
0.98
0.00
2.8
2.4
kpa
8.2
8.0
—
8
73
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
52
0.96
0.00
1.6
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
64
0.94
0.00
1.2
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
61
0.98
0.00
1.3
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
1.9
—
1.2
—
0
8
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
72
0.97
0.00
1.4
1.5
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
3.0
—
9125.8
—
0
6
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
58
0.86
0.00
2.2
2.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
13.7
—
0
5
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
1.9
—
0
6
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
12.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
84
0.95
0.00
1.8
1.5
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
44.8
—
0
5
(3009871) Measles virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
82
0.98
0.00
5.1
1.7
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_UVEAMELANOMA – Melanoma of uvea
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).